$ZMNeutralMed

Is Zoom Stock A Buy After The Anthropic IPO Hype?

Zoom shares rose to about $112 after a Q1 FY27 earnings beat and a speculative rally tied to Anthropic IPO plans, according to the article. Zoom reported enterprise revenue up 7.2% YoY to $755.7 million, with AI Companion paid users up 184%, and $500.5 million quarterly free cash flow. The stock trades at 18.4x forward earnings ($6.04), above its 4-year average 13.5x, while the article cites Microsoft Teams competition and near-flat enterprise net dollar expansion (99%).

9/10
5/10
Med
Neutral
Post-earnings valuation debate after shares rally to ~$112 on Anthropic IPO speculation
Aligns with momentum being expensive: positive turnaround narrative offset by valuation/margin-of-safety concerns

Fundamentals show an AI-driven turnaround, but the article argues the stock’s $112 valuation already prices a best-case scenario amid structural churn/price-power drag.

Zoom’s Q1 FY27 beat and AI Companion growth are cited, alongside valuation expansion and ongoing Microsoft Teams competitive pressure.

Near-term upside may be capped unless AI monetization accelerates enough to offset Microsoft/Online commoditization; downside risk increases if multiple compresses.

Background

The article frames Zoom’s shift from a “single-use utility” toward an AI-driven enterprise platform, then ties a speculative rally to Anthropic IPO chatter.

Why it matters

It sets up a valuation/margin-of-safety decision: strong AI-led operating momentum versus persistent structural pressure from Microsoft Teams and weak legacy Online growth.

Market relevance

Traders are prompted to reassess whether Zoom’s AI turnaround is sufficiently durable to warrant a higher-than-historical forward multiple after a momentum-driven run.

Market effects

Reinforces the market’s focus on enterprise UC/communications vendors’ AI monetization versus suite bundling (Teams) and churn resilience.

No specific regional impact described.

No explicit global macro/regional driver cited; impact is primarily company-specific and competitive within enterprise software.

Alternative perspectives

If AI Companion paid-user growth sustains and cross-sell expands beyond ZCX deals, the premium multiple could remain justified despite Microsoft bundling.

The article doesn’t quantify how much of the churn/99% net expansion is driven by mix shift versus true competitive loss, nor does it provide guidance/forward KPIs beyond the cited quarter.

Key entities

  • Zoom

    Subject of the article; Q1 FY27 results, AI Companion growth, cash generation, and valuation discussion at ~$112.

  • Microsoft

    Cited as a competitive inclusion of Teams that pressures Zoom’s pricing power and expansion.

  • Anthropic

    IPO-related hype is described as a driver of speculative momentum in Zoom’s shares.

Related articles

$ZMMedAI 8/10

Zoom launches ZoomMate: the first AI teammate built to turn conversations into completed work

Zoom Communications (NASDAQ: ZM) said it launched ZoomMate, an agentic AI “work surface” generally available today. The tool links Zoom meeting and enterprise conversational context to agentic search, automated workflow execution, and AI-generated deliverables across systems including Salesforce, Jira, Slack, and ServiceNow. ZoomMate starts at $20 per user per month with AI credits, with broader regional rollout expected later in 2026.

$ZMHighAI 9/10

Zoom Communications, Inc. (ZM) Stock Forecasts

Argus reported May 26, 2026 that Zoom Communications raised its full-year guidance after fiscal 1Q results. The article describes Zoom’s “AI first” cloud communications platform, including Zoom Workplace (Meetings, Phone, Team Chat, Docs, Whiteboard) and Zoom Business Services (enterprise sales and customer-experience tools).